By Doug Madison
BTIG Research set a $13.00 price objective on Histogenics Corp (NASDAQ:HSGX) in a research report released on Thursday morning. The firm currently has a a buy rating on the stock.
Shares of Histogenics Corp (NASDAQ:HSGX) traded down 4.48% during mid-day trading on Thursday, hitting $7.88. The stock had a trading volume of 15,222 shares. Histogenics Corp has a 52 week low of $7.04 and a 52 week high of $12.47. The stock has a 50-day moving average of $8. and a 200-day moving average of $9.. The company’s market cap is $100.44 million.
Histogenics Corp (NASDAQ:HSGX) last released its earnings data on Thursday, May 14th. The company reported ($0.60) earnings per share for the quarter, beating the analysts’ consensus estimate of ($1.34) by $0.74. Analysts expect that Histogenics Corp will post $-2.57 EPS for the current fiscal year.
